Skip to content
HLTH 2340

Management of Percutaneous or Permucosal Exposure to Blood and Body Fluid: Letter for Follow-Up Physician

HLTH 2340 is how the emergency department hands an exposed patient back to community care after a needlestick, splash or other blood or body fluid exposure. It records the prophylaxis started and the baseline tests drawn, and lists what the follow-up physician has to arrange, from the rest of the antiretroviral course to repeat serology.

At a glance

Checked October 2026

Form number
HLTH 2340
Issued by
BC Ministry of Health
Where
British Columbia
Completed by
Emergency department physician; acted on by the follow-up physician
Format
Fillable PDF
Language
English

What the HLTH 2340 is for

HLTH 2340 is a letter from the emergency department to the exposed person’s family physician or other follow-up provider. It covers percutaneous and permucosal exposures to blood and body fluids, such as needlestick injuries and splashes. It tells you what prophylaxis was given, which baseline tests were drawn, where to get the results, and what you still need to do. The clinical detail behind it is Chapter 1, Blood and Body Fluid Exposure Management, of the BCCDC Communicable Disease Control Manual.

Who completes it

The emergency department physician completes and signs the letter, stamps it with the health facility, and gives the white copy to the patient to bring to you. The yellow copy goes to the exposed person’s worksite occupational health and the pink copy stays on their chart. As the follow-up physician, your part is acting on the boxes the emergency physician ticked.

How to read and act on the letter

Post-exposure prophylaxis received

The letter records wound cleaning, tetanus prophylaxis, hepatitis B immune globulin, one dose of hepatitis B vaccine, a five-day antiretroviral starter kit, and preliminary counselling. If the starter kit was given, the five-day window is short, so the next step can’t wait for a routine appointment.

Baseline tests and where to get results

Baseline tests may include HIV Ag/Ab, HBsAg, anti-HBs, anti-HBc total, anti-HCV and a pregnancy test. The letter gives a phone number and the department to ask, such as medical records, the emergency department or the lab. The baseline results decide what further testing is needed.

What’s required of you

If antiretrovirals were started, consult the BC Centre for Excellence in HIV/AIDS at 1-888-511-6222 as soon as possible to decide on the rest of a one-month supply and arrange delivery. If a hepatitis B vaccine dose was given, offer or refer for the remaining doses of the schedule.

Follow-up blood tests

Arrange the tests the emergency physician ticked: HIV Ag/Ab at 3 weeks, 6 weeks and 3 months; HCV RNA at 3 weeks when the source is HCV positive or high risk, repeated at 6 months if positive; and anti-HCV, HBsAg, anti-HBs and anti-HBc total at 3 months. A change from non-reactive to reactive on any marker means seroconversion. The patient may also need counselling on infection risk and avoiding transmission.

Common reasons follow-up goes wrong

  • The patient arrives after the five-day starter kit has run out.
  • Baseline results aren’t retrieved, so the need for further testing is unclear.
  • Hepatitis B vaccine doses after the first one are never scheduled.
  • Only the 3-month serology is drawn when earlier HIV or HCV RNA testing was ticked.
  • No one tells the patient about transmission precautions while results are pending.

Submitting and who pays

The letter isn’t submitted anywhere. The patient brings it to you, and you file it on the chart and order the tests on a lab requisition. If the exposure happened at work, the worksite copy supports the occupational health follow-up, and the visit may belong to a WorkSafeBC claim.

Get the official form

Download the current version from BC Ministry of Health each time. Forms change without notice, and an old edition can be returned.

Official page ↗ PDF ↗

Medulla Forms

Fill HLTH 2340 from the visit and the chart.

Upload the fillable PDF to your practice's forms once. Medulla fills it from the visit and the chart open in your EMR, leaves blank anything the record doesn't support, and opens the form for your review. When it's done, save it to the patient's chart in one click.

Free 1-month trial. No credit card required.

Sources for this guide

Questions

Questions we hear a lot.

Who gives the exposed person the rest of their HIV PEP after the starter kit?

The follow-up physician. The letter asks you to consult the BC Centre for Excellence in HIV/AIDS at 1-888-511-6222 as soon as possible to decide whether the patient needs the remainder of a one-month supply of antiretrovirals, and to arrange delivery if required.

What follow-up blood tests does HLTH 2340 ask for?

The form lists HIV Ag/Ab at 3 weeks, 6 weeks and 3 months, HCV RNA at 3 weeks when the source is HCV positive or high risk, and anti-HCV, HBsAg, anti-HBs and anti-HBc total at 3 months. The emergency physician ticks which ones apply.

Does the patient still need follow-up if PEP wasn't started?

Yes. Fraser Health's guidance is that the exposed person needs continued follow-up with a community provider whether or not PEP was started in the emergency department.

Where do the copies of HLTH 2340 go?

The white copy goes to the patient, the yellow copy to the exposed person's worksite occupational health, and the pink copy stays on the exposed person's chart.

Is patient information secure?

Yes. Medulla has a SOC 2 Type II report from an independent auditor, is HIPAA, PIPEDA, and PHIPA compliant, and is built and hosted in Canada, so patient data stays in the country and never gets pasted into consumer AI tools. Everything is encrypted in transit and at rest. See how we protect patient data.

More questions? Browse help.medulla.ca.